Diseño y síntesis química de un análogo de los inhibidores de la HMG-CoA reductasa mediante QSAR
Cardiovascular diseases, mostly related to hyperlipidemia, have a significant impact on the population; it is known that HMG-CoA reductase inhibitors are the first-line medications for their treatment, being the most prescribed worldwide. However, their prolonged use can lead to drug-induced myopath...
- Autores:
-
Blanco Niño, Manuel Andres
Delgado Cruz, Diana Paola
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_7a1f
- Fecha de publicación:
- 2024
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/12092
- Acceso en línea:
- https://hdl.handle.net/20.500.12495/12092
- Palabra clave:
- Hipercolesterolemia
Inhibidores de la HMG CoA-Reductasa
QSAR
Drug Discovery
615.19
Hypercholesterolemia
HMG CoA Reductase Inhibitors
QSAR
Drug Discovery
- Rights
- closedAccess
- License
- Acceso cerrado